Targeting an Early and Substantial Increase in Mean Arterial Pressure Is Critical in the Management of Type 1 Hepatorenal Syndrome: A Combined Retrospective and Pilot Study - Maddukuri, Geetha; Cai, Cindy X.; Munigala, Satish; Mohammadi, Farnaz; Zhang, Zhiwei (Digestive diseases and sciences, 2014)
Keywords: Albumin; Albumins - therapeutic use; Arterial Pressure - drug effects; Biochemistry; Blood pressure; Disease Progression; Disease-Free Survival; Drug Therapy, Combination; Early Medical Intervention; Female; Gastroenterology; Hepatology; Hepatorenal Syndrome - diagnosis; Hepatorenal Syndrome - drug therapy; Hepatorenal Syndrome - mortality; Hepatorenal Syndrome - physiopathology; Humans; Kaplan-Meier Estimate; Liver; Liver Transplantation; Male; Medicine; Medicine & Public Health; Middle Aged; Midodrine - therapeutic use; Octreotide - therapeutic use; Oncology; Original Article; Pilot Projects; Prospective Studies; Renal Dialysis; Retrospective Studies; Time Factors; Transplant Surgery; Transplantation of organs, tissues, etc; Treatment Outcome; Vasoconstrictor Agents - therapeutic use; Vasodilation - drug effects; Early goal-directed therapy; Mean arterial pressure; Vasoconstrictor; Hepatorenal syndrome